On Monday, Mind Medicine Inc (NASDAQ: MNMD) opened lower -7.76% from the last session, before settling in for the closing price of $6.83. Price fluctuations for MNMD have ranged from $5.03 to $12.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -2.36% at the time writing. With a float of $73.35 million, this company’s outstanding shares have now reached $75.10 million.
The extent of productivity of a business whose workforce counts for 74 workers is very important to gauge. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Mind Medicine Inc is 2.67%, while institutional ownership is 54.71%. The most recent insider transaction that took place on Dec 26 ’24, was worth 141,958. In this transaction Chief Executive Officer of this company sold 19,106 shares at a rate of $7.43, taking the stock ownership to the 526,666 shares. Before that another transaction happened on Dec 26 ’24, when Company’s Chief Accounting Officer sold 2,273 for $7.43, making the entire transaction worth $16,888. This insider now owns 97,270 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -2.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.04% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Check out the current performance indicators for Mind Medicine Inc (MNMD). In the past quarter, the stock posted a quick ratio of 7.25.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.55 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
The latest stats from [Mind Medicine Inc, MNMD] show that its last 5-days average volume of 1.83 million was inferior to 2.3 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 50.74%. Additionally, its Average True Range was 0.70.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 16.71%, which indicates a significant decrease from 18.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 69.24% in the past 14 days, which was lower than the 91.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.36, while its 200-day Moving Average is $7.15. Now, the first resistance to watch is $6.59. This is followed by the second major resistance level at $6.87. The third major resistance level sits at $7.11. If the price goes on to break the first support level at $6.07, it is likely to go to the next support level at $5.83. The third support level lies at $5.55 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
There are currently 73,332K shares outstanding in the company with a market cap of 474.82 million. Presently, the company’s annual sales total 0 K according to its annual income of -95,730 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -13,680 K.
